| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/25/2011 | CN102068690A Polyvalent pneumococcal capsular polysaccharide conjugate vaccine and preparation method thereof |
| 05/25/2011 | CN102068634A Externally applied ironing moxibustion clay for human body and manufacturing method thereof |
| 05/25/2011 | CN102068474A Capparis spinosa fruit gel ointment, production method thereof, and application thereof to antirheumatic medicaments |
| 05/25/2011 | CN102068469A Method for improving fatty oil Chinese medicinal extract condensation efficiency and increasing concentration of concentrated solution |
| 05/25/2011 | CN102068459A Enteric coatel tablet taking leech as raw material |
| 05/25/2011 | CN102068456A Chinese medicinal plaster for treating malignant blood diseases |
| 05/25/2011 | CN102068454A Slow-release regulating agent for preventing rumen acidosis and preparation method thereof |
| 05/25/2011 | CN102068453A Stable complex vitamin composite and preparation method thereof |
| 05/25/2011 | CN102068442A Prescription for preventing white-spot disease of turtles |
| 05/25/2011 | CN102068431A Carbazole sulfamide-derived anti-tumor medicine tablets and preparation method thereof |
| 05/25/2011 | CN102068425A Improved oseltamivir phosphate medicinal composition |
| 05/25/2011 | CN102068419A Curcumin composition |
| 05/25/2011 | CN102068418A Sofalcone sustained-release pellet capsule preparation and preparation method thereof |
| 05/25/2011 | CN102068416A Itraconazole-containing oral solid preparation and preparation method thereof |
| 05/25/2011 | CN102068415A Carbazole sulfonamide anti-tumor medicine dispersible tablets and preparation method thereof |
| 05/25/2011 | CN102068414A Levetiracetam sustained-release tablets and preparation method thereof |
| 05/25/2011 | CN102068413A 比阿培南冻干制剂及其制备方法 Biapenem lyophilized formulation and preparation method |
| 05/25/2011 | CN102068412A Enteric targeted tilmicosin particles and preparation method thereof |
| 05/25/2011 | CN102068411A Carbazole sulfonamide type anti-tumor medicament granules and preparation method thereof |
| 05/25/2011 | CN102068410A Solid preparation of ade fovird ip iv oxil liposome |
| 05/25/2011 | CN102068407A Cabazitaxel injection and preparation method thereof |
| 05/25/2011 | CN102068406A Polymer medicament carrying micelle and preparation method thereof |
| 05/25/2011 | CN102068405A Ketoprofen gel and preparation method thereof |
| 05/25/2011 | CN102068404A Nimesulide temperature sensitive hydrogel and preparation method thereof |
| 05/25/2011 | CN102068403A Nanometer water-based gel and preparation process thereof |
| 05/25/2011 | CN101843594B Alprostadil freeze-dried emulsion for injection and preparation method thereof |
| 05/25/2011 | CN101810588B Pantoprazole sodium freeze-drying medicinal composition for injection and preparation method thereof |
| 05/25/2011 | CN101690777B Formula of polygonatum chewable tablets and preparation method thereof |
| 05/25/2011 | CN101670114B Compound of survivin and heat shock protein, preparation method and applications thereof |
| 05/25/2011 | CN101618221B Preparation method and application of functionalized nano-carbon tube anti-neoplastic drug carrier |
| 05/25/2011 | CN101586256B Preparation of porosity electrospun fiber |
| 05/25/2011 | CN101584672B Clofarabine pharmaceutical composition freeze-dried powder injection and preparation method thereof |
| 05/25/2011 | CN101579325B Metformin hydrochloride controlled-release tablet and preparation method thereof |
| 05/25/2011 | CN101579315B Immunoliposome based on endostatin gene, preparation method and application thereof |
| 05/25/2011 | CN101564537B 3, 5-dihydroxy-4-isopropyl diphenyl ethylene-ethyl bromoacetate-polyoxyethylene compound and synthetic method thereof |
| 05/25/2011 | CN101559231B High shearing production method for film coating agent |
| 05/25/2011 | CN101554373B Caffeic acid composition and preparation method thereof |
| 05/25/2011 | CN101519451B Recombinant human cytotoxic T lymphocyte associate antigen-4 fusion protein gene (sCTLA4-Ig) and pharmaceutical composition thereof |
| 05/25/2011 | CN101461879B Plaster for treating neck, spine, protrusion of lumbar vertebral disc, hyperosteogeny, arthralgia and myalgia |
| 05/25/2011 | CN101455729B Kangfulingshuan medicine production technique |
| 05/25/2011 | CN101444527B Medicament for curing oral ulcer |
| 05/25/2011 | CN101420946B Tamsulosin-containing percutaneous absorption type preparation |
| 05/25/2011 | CN101322784B Medicament with stomach-regulating and antidiarrheal efficacy and producing method thereof |
| 05/25/2011 | CN101284885B Amphipathic cyclodextrin polymers, preparation method and use |
| 05/25/2011 | CN101249278B Bone induction material and preparation method and application thereof |
| 05/25/2011 | CN101219201B Traditional Chinese medicine liquid capsule and its preparing method |
| 05/25/2011 | CN101219118B Impulse released oral medication preparation |
| 05/25/2011 | CN101185759B Anti-angiogene compositions and methods of use |
| 05/25/2011 | CN101143154B Method for preparing surface cladding super-micro traditional Chinese medicine material crude slice |
| 05/24/2011 | US7947841 Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide |
| 05/24/2011 | US7947737 Method of treating hypertension and reducing serum lipase activity |
| 05/24/2011 | US7947736 Oligomeric compounds |
| 05/24/2011 | US7947725 Liquid pharmaceutical formulations of palonosetron |
| 05/24/2011 | US7947724 Liquid pharmaceutical formulations of palonosetron |
| 05/24/2011 | US7947659 iRNA agents targeting VEGF |
| 05/24/2011 | US7947657 Method for selective inhibition of human N-myc gene in N-myc expressing tumors through antisense and antigen peptido-nucleic acids (PNA) |
| 05/24/2011 | US7947655 Methods for making proteins containing free cysteine residues |
| 05/24/2011 | US7947310 Method of treating stroke or brain injury patients based on the intravenous administration of magnesium cations and concurrent administration of an oxygen gas mixture |
| 05/24/2011 | US7947309 Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants |
| 05/24/2011 | US7947308 Effervescent powders for inhalation |
| 05/24/2011 | US7947306 Modifications of solid 3-sn-phosphoglycerides |
| 05/24/2011 | US7947303 Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition |
| 05/24/2011 | US7947302 Antithrombotic coating for drug eluting medical devices |
| 05/24/2011 | US7947299 Compositions and techniques for localized therapy |
| 05/24/2011 | US7947295 Ophthalmic compositions containing a synergistic combination of two polymers |
| 05/24/2011 | US7947289 Multimeric protein toxins to target cells having multiple identifying characteristics |
| 05/24/2011 | US7947282 Methods of treatment using vascular occlusion in combination therapies |
| 05/24/2011 | US7947261 Moiety is positioned between a water-soluble polymer and a reactive group; water soluble polymer such as polyethylene glycol containing a urethane linkage moiety for example, and a reactive group for conjugating with biodrugs |
| 05/24/2011 | US7947257 Method of intranasal administration of granisetron |
| 05/24/2011 | CA2633170C Butylphthalide intravenous emulsion and application thereof |
| 05/24/2011 | CA2582767C Solid formulation with improved solubility and stability and method for producing said formulation |
| 05/24/2011 | CA2531239C Pharmaceutical formulations for intranasal administration of protein comprising a chitosan or a derivative thereof |
| 05/24/2011 | CA2493764C Improved treatment of cancer with glutamine |
| 05/24/2011 | CA2491701C Fredericamycin derivatives as drugs for tumor treatment |
| 05/24/2011 | CA2491313C Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use |
| 05/24/2011 | CA2490007C Biodegradable triblock copolymers, synthesis methods therefor, and hydrogels and biomaterials made there from |
| 05/24/2011 | CA2489665C Popping oral administration form |
| 05/24/2011 | CA2479737C Nanoparticulate compositions of map kinase inhibitors |
| 05/24/2011 | CA2463495C Compositions having a combination of immediate release and controlled release characteristics |
| 05/24/2011 | CA2452412C Biodegradable injectable implants and related methods of manufacture and use |
| 05/24/2011 | CA2440596C Soluble heterodimeric cytokine receptor |
| 05/24/2011 | CA2428985C Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
| 05/24/2011 | CA2420621C Microparticle compositions and methods for the manufacture thereof |
| 05/24/2011 | CA2415403C Method for obtaining aqueous formulations of oxidation-sensitive active principles |
| 05/24/2011 | CA2382840C Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof |
| 05/24/2011 | CA2358459C Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions |
| 05/24/2011 | CA2345277C Methods for isolation, quantification, characterization and modulation of antigen-specific t cells |
| 05/24/2011 | CA2344816C Medicinal aerosol formulation |
| 05/24/2011 | CA2341642C Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
| 05/24/2011 | CA2339487C Targeting and prolonging association of drugs to the luminal surface of the pulmonary vascular endothelial cells |
| 05/24/2011 | CA2270913C Human tumor necrosis factor receptor-like 2 |
| 05/24/2011 | CA2264258C Novel antimicrobial peptide |
| 05/24/2011 | CA2258017C Immunstimulating lipid formulation |
| 05/24/2011 | CA2184890C Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus |
| 05/24/2011 | CA1341615C Targeted multifunctional proteins |
| 05/19/2011 | WO2011060281A1 Hydrophobic block conjugated therapeutic agents |
| 05/19/2011 | WO2011060195A2 Topical eutectic formulation |
| 05/19/2011 | WO2011059909A1 Polysaccharide gel formulation having multi-stage bioactive agent delivery |
| 05/19/2011 | WO2011059416A1 Prophylactic antioxidant agent for protecting the tissues of an organism from the action of negative ecological factors or the consequences of smoking tobacco |
| 05/19/2011 | WO2011059326A2 Hydrogels based on polymers of dextran tyramine and tyramine conjugates of natural polymers |